Prognosis for women with breast cancer not worse for those with family history
the ONA take:
A family history of breast cancer does not influence prognosis for women with breast cancer, according to results of a new large study from UK researchers. Approximately one-quarter of breast cancer cases in developed countries are thought to be hereditary.
The researchers conducted an analysis of the Prospective Outcomes in Sporadic versus Hereditary breast cancer (POSH) study, which included 2,850 women younger than 41 years with a breast cancer diagnosis and were treated in the United Kingdom.
POSH investigators had recorded information on patients’ tumors, treatment, family history of breast/ovarian cancer, and personal characteristics over a 15-year period.
In this study, no significant differences were found in cancer recurrence rates between women with a family history and those with no family history.
Future investigations will focus on the impact of certain gene variants on the effectiveness of different anticancer treatments.
A family history of breast cancer does not influence prognosis for women with breast cancer.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|